U.S. Semiconductors Stock News

Trump Media & Technology Group Corp. recently appointed Kevin J. McGurn as Interim CEO, succeeding Devin Nunes and tasking him with leading the company’s efforts across social media, streaming, and mergers and acquisitions, while board member Eric Swider resigned earlier in April without any reported dispute. The combination of an abrupt CEO transition and board change places heightened attention on how McGurn will coordinate the company’s diverse media, cryptocurrency, fusion, and ETF...

What U.S. Bancorp’s Recent Returns Tell You U.S. Bancorp (USB) has drawn fresh attention after a solid stretch of share performance, with the stock showing gains over the past week, month and past 3 months, alongside a positive one year total return. See our latest analysis for U.S. Bancorp. That mix of a 10.9% 1 month share price return and a 51.9% 1 year total shareholder return suggests momentum has been building, with the latest 1 day share price slip of 0.3% looking more like a pause...

If you are wondering whether Williams-Sonoma at around US$202 per share still offers value, the next sections break down what the current price might be implying about the business. The stock has recently recorded returns of 4.4% over 7 days, 13.4% over 30 days, 7.7% year to date, 44.6% over 1 year and 262.4% over 3 years. This naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Williams-Sonoma as a well known name in premium home...

Wondering if Northwest Bancshares at around US$13.22 is offering solid value or just looks inexpensive on the surface? This article walks through what the current price may be implying about the stock. The share price has seen mixed short term moves, with a 1.2% decline over the last 7 days but an 8.3% gain over 30 days and returns of 10.4% year to date and 22.2% over 1 year. Recent company developments, regulatory updates or sector headlines can all influence how investors think about banks...

If you are trying to work out whether Pagaya Technologies at about US$14.32 is genuinely good value or just riding a narrative, the recent numbers give you plenty to think about. The stock has returned 10.1% over the last 7 days, 34.6% over the last 30 days, 52.7% over the last year and 43.8% over 3 years, although the year to date return of 35.7% and 5 year return of 87.8% show that the ride has not been smooth. Recent coverage around Pagaya Technologies has focused on its role as a...

Recent Performance Snapshot Invitation Homes (INVH) has drawn attention after a recent move in its share price, trading at $26.94. Short term returns are mixed, with a 1 day decline and gains over the past week and month. See our latest analysis for Invitation Homes. The recent 10.46% 1 month share price return contrasts with a weaker year to date share price return of 2.81% and a 1 year total shareholder return of 17.49%. This suggests short term momentum is building while longer term...

Glaukos Corporation recently announced that the U.S. Centers for Medicare and Medicaid Services has granted Epioxa a unique, permanent HCPCS J-code (J2789) for keratoconus treatment, effective July 1, 2026, aimed at simplifying billing and reimbursement for providers. This permanent J-code assignment is important because it can make it easier for payers and clinicians to adopt Epioxa, potentially improving patient access to treatment for a frequently underdiagnosed, sight-threatening corneal...

Wondering whether Churchill Downs at around US$90.84 is a bargain or a value trap? This article breaks down what the current share price might be implying about the stock. The stock has been mixed recently, with a 1.2% decline over the last week, an 8.5% gain over the last month, and returns of an 18.9% decline year to date and an 11.5% decline over the last year. Those returns sit against a longer backdrop where the share price shows a 27.7% decline over three years and a 15.7% decline over...

Wondering if Ameriprise Financial is offering good value at its current price, or if the recent run means you might be late to the story? The stock last closed at US$461.08, with a 5.0% gain over 30 days, a small 0.2% decline over 7 days, and returns of 93.7% over 5 years and 65.8% over 3 years. These figures may catch your eye if you are weighing growth potential against risk. Recent coverage around Ameriprise Financial has focused on its role in the broader capital markets sector and how...

What Allegro MicroSystems’ Recent Share Performance Signals for Investors Allegro MicroSystems (ALGM) has been drawing attention after a strong share price move, with returns of about 38% over the past month and 21% over the past 3 months, prompting closer investor interest. See our latest analysis for Allegro MicroSystems. At a share price of $41.28, Allegro MicroSystems has seen strong momentum build recently, with a 30 day share price return of 37.83% and a 1 year total shareholder return...

In recent weeks, Atlanticus Holdings announced that its acquisition of Mercury Financial has roughly doubled its balance sheet to about US$7.00 billion and brought a US$3.00 billion portfolio under its management approach. This move has sharpened attention on how repricing the acquired assets and integrating operations could influence the company’s earnings profile and efficiency. For investors, the most interesting development is how integrating Mercury Financial’s portfolio may allow...

DoubleVerify Holdings (NYSE:DV) has entered a new partnership with Spectrum Reach to launch the first Certified Transparent Streaming program. The collaboration focuses on program level ad transparency across streaming TV and CTV campaigns. This move aims to give advertisers clearer insight into where their ads appear within specific streaming programs. For investors tracking NYSE:DV, the development comes with the stock trading around $10.66, after a 5.3% gain over the past week and 6.1%...

Alcoa is in talks to sell its defunct Messina smelter to NYDIG for conversion into a large scale Bitcoin mining data center. The deal would repurpose an inactive industrial site into a cryptocurrency-focused facility backed by a digital asset manager. The potential transaction connects legacy aluminum production assets with the growing demand for energy intensive computing infrastructure. For Alcoa (NYSE:AA), the Messina negotiations arrive with the stock at $67.15 and substantial long term...

Timken overview and recent performance context Timken (TKR) has attracted investor attention after recent share price strength, with the stock closing at $108.75 and posting positive returns over the past week, month, past 3 months and year to date. See our latest analysis for Timken. Recent share price momentum has been firm, with a 30 day share price return of 14.17% and a year to date share price return of 26.03%. The 1 year total shareholder return of 79.37% points to strong longer term...

Ionis Pharmaceuticals recently reported additional positive results from its pivotal Phase 1-3 trial of zilganersen in Alexander disease, showing statistically significant stabilization of gait speed and broad symptom benefits over 60 weeks, with the drug currently under FDA Priority Review and a PDUFA decision date set for September 22, 2026. Beyond motor endpoints, exploratory data showing reduced glial fibrillary acidic protein levels and consistently better patient- and...

AEVEX (NYSE:AVEX) has completed its public debut with an IPO that brought in fresh capital for the company. The company is using a portion of the new funds to acquire a stake in Athena Technology Solutions Holdings, expanding its presence in airborne intelligence. High profile mentions in financial media have increased attention on AEVEX's role in defense technology, particularly around drones and autonomous systems. AEVEX comes to market with NYSE:AVEX now trading around $35.99 and a year...

Why Zai Lab Stock Is Back on Investor Radar Zai Lab (NasdaqGM:ZLAB) has drawn fresh attention after a recent swing in performance, with the share price up over the past month and past 3 months, putting its biopharma pipeline back in focus for investors. See our latest analysis for Zai Lab. The recent 30 day share price return of 35.10% and 90 day share price return of 29.72% contrast with a 1 year total shareholder return of 24.87% and 5 year total shareholder return of 86.21%. This indicates...

For investors considering whether Natera at around US$205 per share still offers value, or whether the recent run has already priced in the story, this article focuses on a straightforward question: what you are paying versus what you might be getting. The stock has been volatile recently, with a 4.3% decline over the past 7 days, a 5.2% gain over 30 days, and returns of a 10.2% decline year to date but 42.0% over 1 year and very large gains over 3 years. Recent news coverage has centered on...

Wondering whether HP's current share price reflects its true worth, or if the market is missing something important about this long established name in tech? HP's share price recently closed at US$21.09, with returns of 11.1% over 7 days and 15.4% over 30 days, while the 1 year return sits at an 8.4% decline and the 5 year return at a 26.7% decline. Recent coverage has focused on HP's position within the broader tech sector and how investors are reassessing established hardware and services...

For investors wondering whether Ulta Beauty at about US$570 a share is offering value or stretching expectations, this article walks through what the current price might imply for you as a shareholder. The stock has returned 7.0% over the last week, 7.6% over the last month, an 8.0% decline year to date, and 50.6% over the past year, which can influence how the market views both its potential and its risks. Recent attention on Ulta Beauty has focused on its role as a major U.S. beauty...

Sana Biotechnology and Mayo Clinic recently announced a collaboration to advance SC451, a hypoimmune-modified pancreatic islet cell therapy for type 1 diabetes, with Mayo contributing clinical expertise and making an initial US$25,000,000 equity investment plus an option for additional funding. The partnership aims to create standardized, scalable protocols for handling, delivering, and monitoring SC451 across diverse care settings, potentially strengthening both organizations’ roles in...

Over the last 7 days, the United States market has risen by 1.3% and is up 35% over the past year, with earnings expected to grow by 16% annually in the coming years. In this environment of robust growth, identifying stocks that are potentially undervalued can offer opportunities for investors seeking value amidst a rising market.

In April 2026, NASA selected Synopsys, Inc. and EMA to use advanced Ansys simulation tools and ground-based testing to verify Artemis lunar spacesuit compatibility with the Moon’s plasma and regolith environment, while also working with Cesium and NASA’s Glenn Research Center to model lunar communications coverage using Synopsys’ digital mission engineering platform. This collaboration highlights how Synopsys’ chip-to-systems simulation capabilities are being applied to high-stakes aerospace...

If you are wondering whether Himax Technologies at around US$11.64 still offers value, it helps to line up the recent share price performance against what the fundamentals suggest the business might be worth. The stock has posted returns of 16.6% over the past 7 days, 35.5% over 30 days, 36.5% year to date, 90.0% over 1 year, 107.4% over 3 years and 12.9% over 5 years, which naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused...